Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines · Delayed Price · Currency is PHP 1.040
-0.040 (-3.70%)
At close: Aug 7, 2026
PSE:EURO Financials Overview
Financials in millions PHP. Fiscal year is January - December.
Millions PHP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,841 | 6,868 | 5,796 | 5,264 | 4,224 | 3,587 |
Revenue Growth | 9.33% | 18.50% | 10.11% | 24.62% | 17.75% | -6.31% |
Gross Profit Gross Profit Growth | 2,470 | 2,439 | 2,012 | 1,894 | 1,493 | 1,438 |
Operating Income Operating Income Growth | 902.91 | 899.65 | 669.03 | 652.58 | 440.44 | 411.1 |
Net Income Net Income Growth | 486.88 | 470.3 | 337.68 | 289.95 | 199.89 | 169.05 |
Earnings Per Share EPS Growth | 0.11 | 0.11 | 0.08 | 0.07 | 0.05 | 0.04 |
EPS Growth | 25.62% | 37.50% | 13.46% | 45.05% | 21.52% | -20.00% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacturing Pharmaceutical Products Manufacturing Pharmaceutical Products Growth | 5,072 | 4,398 | 4,032 | 3,162 | 2,688 |
Providing Health and Other Care Services Providing Health and Other Care Services Growth | 990.92 | 655.68 | 493.87 | 453.8 | 610.51 |
Development and Operation of Quick Service Restaurant Development and Operation of Quick Service Restaurant Growth | 964.66 | 887.13 | 823.09 | 661.44 | 344.06 |
Elimination Elimination Growth | -158.97 | -144.31 | -85.21 | -53.22 | -55.62 |
Total Total Growth | 6,868 | 5,796 | 5,264 | 4,224 | 3,587 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,698 | 1,518 | 1,091 | 1,083 | 806.31 | 727.89 |
Total Debt Total Debt Growth | 4,155 | 4,312 | 4,293 | 4,039 | 3,681 | 3,421 |
Net Cash (Debt) Net Cash Growth | -2,457 | -2,794 | -3,202 | -2,956 | -2,874 | -2,693 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.60 | -0.68 | -0.78 | -0.72 | -0.70 | -0.65 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,081 | 970.72 | 246.81 | 354.13 | 148.23 | 488.4 |
Capital Expenditures CapEx Growth | -243.67 | -267.93 | -196.08 | -291.87 | -88.89 | -285.57 |
Free Cash Flow Free Cash Flow Growth | 836.92 | 702.78 | 50.73 | 62.26 | 59.35 | 202.83 |
Free Cash Flow Growth | 993.87% | 1285.29% | -18.52% | 4.91% | -70.74% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.10% | 35.52% | 34.71% | 35.98% | 35.35% | 40.08% |
Operating Margin | 13.20% | 13.10% | 11.54% | 12.40% | 10.43% | 11.46% |
Pretax Margin | 9.62% | 9.28% | 7.55% | 7.57% | 6.64% | 6.45% |
Profit Margin | 7.12% | 6.85% | 5.83% | 5.51% | 4.73% | 4.71% |
FCF Margin | 12.23% | 10.23% | 0.88% | 1.18% | 1.41% | 5.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.070 | - | 0.070 | 0.060 | 0.035 | 0.020 |
Dividend Per Share Growth | 16.67% | - | 16.67% | 71.43% | 75.00% | 33.33% |
Dividend Yield | 6.73% | - | 9.12% | 9.15% | 4.81% | 1.77% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.45 | 8.74 | 9.99 | 10.64 | 17.90 | 34.06 |
P/FCF Ratio | 5.11 | 5.85 | 66.47 | 49.54 | 60.28 | 28.38 |
PS Ratio | 0.63 | 0.60 | 0.58 | 0.59 | 0.85 | 1.61 |